Trending

Japan

Promethera looks to Asia with €10m investment

Promethera looks to Asia with €10m investment

Belgium-based liver disease specialists Promethera Biosciences have received a leg-up for the Asian market in the form of

X

Promethera looks to Asia with €10m investment

https://pharmaphorum.com/news/promethera-looks-to-asia-with-e10m-investment/

AstraZeneca gets further approval for Tagrisso in Japan

AstraZeneca gets further approval for Tagrisso in Japan

AstraZeneca received approval from the Japanese regulator following a priority review of Tagrisso (osimertinib) as a first-line treatment

X

AstraZeneca gets further approval for Tagrisso in Japan

https://pharmaphorum.com/news/astrazeneca-tagrisso-approval/

AstraZeneca cancer drugs approved in Japan

AstraZeneca cancer drugs approved in Japan

AstraZeneca secured a fast approval of lung and breast cancer drugs with usually sluggish Japanese regulators, just months

X

AstraZeneca cancer drugs approved in Japan

https://pharmaphorum.com/r-d/astrazenecas-cancer-drugs-approved-japan/

AZ tried to buy Daiichi Sankyo last year – report

AZ tried to buy Daiichi Sankyo last year – report

Trading in shares of Daiichi Sankyo was suspended yesterday.

X

AZ tried to buy Daiichi Sankyo last year – report

https://pharmaphorum.com/news/az-tried-buy-daiichi-sankyo-last-year-report/

Regulatory timelines in the Asia-Pacific

Regulatory timelines in the Asia-Pacific

Snapshot of clinical trial application processes in the region.

X

Regulatory timelines in the Asia-Pacific

https://pharmaphorum.com/views-and-analysis/regulatory-timelines-asia-pacific/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com